Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder

doi:10.1093/europace/euaa057

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Axel Brandes^*
, Harry J G M Crijns
, Michiel Rienstra
, Paulus Kirchhof
, Erik L Grove
, Kenneth Bruun Pedersen
, Isabelle C Van Gelder

^*Corresponding author for this work

KI, OUH, Research unit of Cardiology (Odense)

University Medical Center Groningen
Aarhus University Hospital
Cardiovascular Research Institute Maastricht
Odense University Hospital
University of Birmingham
University Hospitals Birmingham NHS Foundation Trust

Research output: Contribution to journal › Journal article › Research › peer-review

349 Downloads (Pure)

Abstract

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

Original language	English
Journal	EP - Europace
Volume	22
Issue number	8
Pages (from-to)	1149-1161
ISSN	1099-5129
DOIs	https://doi.org/10.1093/europace/euaa057
Publication status	Published - 1. Aug 2020

Bibliographical note

Keywords

Anticoagulation
Atrial fibrillation
Atrial flutter
Electrical cardioversion
Pharmacological cardioversion
Thromboembolism

Documents & Links

10.1093/europace/euaa057Licence: CC BY-NC

Open Access VersionFinal published version, 561 KBLicence: CC BY-NC

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{03d63b84be7441e18bcad65bbf4c6b15,

title = "Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure",

abstract = "Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.",

keywords = "Anticoagulation, Atrial fibrillation, Atrial flutter, Electrical cardioversion, Pharmacological cardioversion, Thromboembolism",

author = "Axel Brandes and Crijns, \{Harry J G M\} and Michiel Rienstra and Paulus Kirchhof and Grove, \{Erik L\} and Pedersen, \{Kenneth Bruun\} and \{Van Gelder\}, \{Isabelle C\}",

note = "{\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2020",

month = aug,

day = "1",

doi = "10.1093/europace/euaa057",

language = "English",

volume = "22",

pages = "1149--1161",

journal = "EP - Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Cardioversion of atrial fibrillation and atrial flutter revisited

T2 - current evidence and practical guidance for a common procedure

AU - Brandes, Axel

AU - Crijns, Harry J G M

AU - Rienstra, Michiel

AU - Kirchhof, Paulus

AU - Grove, Erik L

AU - Pedersen, Kenneth Bruun

AU - Van Gelder, Isabelle C

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

AB - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Atrial flutter

KW - Electrical cardioversion

KW - Pharmacological cardioversion

KW - Thromboembolism

U2 - 10.1093/europace/euaa057

DO - 10.1093/europace/euaa057

M3 - Journal article

C2 - 32337542

SN - 1099-5129

VL - 22

SP - 1149

EP - 1161

JO - EP - Europace

JF - EP - Europace

IS - 8

ER -

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Abstract

Bibliographical note

Keywords

Documents & Links

SDU Link

Fingerprint

Cite this